We recently demonstrated that sustained elevation of IL-6 in obese mice receiving IL-12+ IL-18 contributes to the delayed resolution of AP in obesity and is associated with increased production of osteopontin and tissue inhibitor of metalloproteinase-1 (TIMP-1) [5]. The gene discussed is IL18; the disease is alkaline phosphatase measurement.